Vaccine Therapy in Treating Patients With Metastatic Cancer

NCT00020267 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Lung Cancer
Adult Soft Tissue Sarcoma
Colorectal Cancer
Bone Cancer
Ovarian Sarcoma
Melanoma
Colon Cancer
Rectal Cancer
Breast Cancer
Eye Cancer
Uterine Sarcoma

Interventions

DRUG: interleukin-2
DRUG: MAGE-12 peptide vaccine
DRUG: Montanide ISA-51

Sponsor

National Cancer Institute (NCI)